Literature DB >> 12508087

A placebo-controlled comparison of effects of repetitive doses of betamethasone and dexamethasone on lung maturation and lung, liver, and body weights of mouse pups.

Himet Ozdemir1, Tevfik Guvenal, Meral Cetin, Tijen Kaya, Ali Cetin.   

Abstract

The aim of this study was to compare in vivo effects of single and repetitive doses of betamethasone (BETA) and dexamethasone (DEX) administered to pregnant mice on lung maturation and lung, liver, and body weights (LLBW) of their pups. One hundred and eighty gravid Swiss albino mice were randomly assigned to 1 of 6 groups (n = 30) and administered either BETA, DEX, or saline as a single dose at 14 d gestation or repetitive doses twice daily at 14 and 15 d gestation. All the study groups were then divided into three sets (n = 10). The mice in the second sets were redivided into three subsets randomly (including four, three, and three mice). All gestations in the first sets were terminated at 16.5 d gestation to observe the neonatal breathing pattern (scale to 0-5; 5 is unlabored breathing) of male and female pups whereas other sets had normal delivery. The pups in first, second, and third sets were killed for evaluation in the first set after the evaluation of breathing pattern, in the subsets of second set on postnatal d 1, 3, and 5, and in the third set on postnatal d 90. We recorded maternal body weights at 0 and 16.5 d gestation, and LLBW, the lung/body weight ratio of pups, sex, and the amount of live and dead births per litter. Pups exposed to BETA and DEX had significantly lower maternal weight compared with the saline groups. The death litter size was significantly higher in pups exposed to repetitive doses of DEX than the other treatments. Sex had no significant effect on breathing score and LLBW. Pups exposed to repetitive doses of BETA and DEX presented a higher breathing score than the other groups. The breathing score was significantly higher with BETA than DEX after their repetitive use. The LLBW were significantly less in the treatment groups, especially in the group exposed to repetitive doses of DEX. In conclusion, repetitive doses of BETA and DEX lead to increased fetal lung maturation, but this may be at the expense of fetal and neonatal growth. DEX is less potent in accelerating lung maturation than BETA but it causes more reduction in fetal and neonatal growth.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12508087     DOI: 10.1203/00006450-200301000-00017

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  9 in total

1.  Effect of maternal betamethasone administration on feto-placental vascular resistance in the mouse†.

Authors:  Lindsay S Cahill; Clare L Whitehead; Sebastian R Hobson; Greg Stortz; John C Kingdom; Ahmet Baschat; Kellie E Murphy; Lena Serghides; Christopher K Macgowan; John G Sled
Journal:  Biol Reprod       Date:  2019-10-25       Impact factor: 4.285

Review 2.  Controversy: antenatal steroids.

Authors:  Ronald Wapner; Alan H Jobe
Journal:  Clin Perinatol       Date:  2011-09       Impact factor: 3.430

3.  Prenatal glucocorticoid administration accelerates the maturation of fetal rat hepatocytes.

Authors:  Tsukasa Kobayashi; Yuko Takeba; Yuki Ohta; Masanori Ootaki; Keisuke Kida; Minoru Watanabe; Taroh Iiri; Naoki Matsumoto
Journal:  Mol Biol Rep       Date:  2022-03-19       Impact factor: 2.742

4.  Preclinical evaluation of human secretoglobin 3A2 in mouse models of lung development and fibrosis.

Authors:  Yan Cai; Melissa E Winn; John K Zehmer; William K Gillette; Jacek T Lubkowski; Aprile L Pilon; Shioko Kimura
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-08       Impact factor: 5.464

5.  Role of secretoglobin 3A2 in lung development.

Authors:  Reiko Kurotani; Takeshi Tomita; Qian Yang; Bradley A Carlson; Chi Chen; Shioko Kimura
Journal:  Am J Respir Crit Care Med       Date:  2008-06-05       Impact factor: 21.405

6.  Sex differences in modulation of fetoplacental vascular resistance in growth-restricted mouse fetuses following betamethasone administration: comparisons with human fetuses.

Authors:  Lindsay S Cahill; Shiri Shinar; Clare L Whitehead; Sebastian R Hobson; Greg Stortz; Viji Ayyathurai; Anjana Ravi Chandran; Anum Rahman; John C Kingdom; Ahmet Baschat; Kellie E Murphy; Lena Serghides; Christopher K Macgowan; John G Sled
Journal:  Am J Obstet Gynecol MFM       Date:  2020-10-06

7.  Transgenically-expressed secretoglobin 3A2 accelerates resolution of bleomycin-induced pulmonary fibrosis in mice.

Authors:  Yan Cai; Mitsuhiro Yoneda; Takeshi Tomita; Reiko Kurotani; Minoru Okamoto; Taketomo Kido; Hiroyuki Abe; Wayne Mitzner; Arjun Guha; Shioko Kimura
Journal:  BMC Pulm Med       Date:  2015-07-16       Impact factor: 3.317

8.  Effects of antenatal betamethasone on preterm human and mouse ductus arteriosus: comparison with baboon data.

Authors:  Elaine L Shelton; Nahid Waleh; Erin J Plosa; John T Benjamin; Ginger L Milne; Christopher W Hooper; Noah J Ehinger; Stanley Poole; Naoko Brown; Steven Seidner; Donald McCurnin; Jeff Reese; Ronald I Clyman
Journal:  Pediatr Res       Date:  2018-07-06       Impact factor: 3.756

9.  Dexamethasone Administration During Late Gestation Has No Major Impact on Lipid Metabolism, but Reduces Newborn Survival Rate in Wistar Rats.

Authors:  Katia Motta; Patricia R L Gomes; Paola M Sulis; Silvana Bordin; Alex Rafacho
Journal:  Front Physiol       Date:  2018-07-03       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.